The company
Anika Therapeutics Inc.
ANIK · Nasdaq
ANIK stood above a rising 150-day average in 33 of the last 52 weekly readings, including each of the last 33 weeks. It is 17.4% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 33 in a row
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $529K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 11
- Institutions holding
- 129 (+4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 33 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
11 disclosed lines: House 11, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Tom Malinowski House: U.S. House ClerkNJ07 | bought | $1k–$15k | 2 Mar 2020filed 5 Mar 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | bought | $1k–$15k | 28 Feb 2020filed 26 Aug 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | bought | $1k–$15k | 27 Feb 2020filed 26 Aug 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | bought | $15k–$50k | 26 Feb 2020filed 5 Mar 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | sold | $1k–$15k | 28 Jan 2020filed 26 Aug 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | sold | $1k–$15k | 29 Oct 2019filed 26 Aug 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | bought | $50k–$100k | 1 Aug 2019filed 26 Aug 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | sold | $1k–$15k | 29 Jul 2019filed 26 Aug 2021 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $15k–$50k | 10 Dec 2018filed 2 Jan 2019 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 28 Jun 2017filed 7 Jul 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $15k–$50k | 28 Dec 2016filed 5 Jan 2017 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Gary P. FischettiDirector | bought | 1,000at $20.32 | 4 Aug 2026filed 5 Aug 2026 |
| Gary P. FischettiDirector | bought | 1,000at $20.75 | 3 Aug 2026filed 5 Aug 2026 |
| John B. Henneman IIIDirector | bought | 5,000at $14.66 | 1 May 2026filed 4 May 2026 |
| Stephen D. GriffinPresident and CEO | bought | 12,200at $12.29 | 30 Apr 2026filed 30 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 1,449,671$21.2M | -145,222−9.1% |
| Caligan Partners LPunchanged · filed 14 Aug 2026 | 1,435,130$21.0M | 00.0% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 614,320$9.0M | -257,746−29.6% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 572,113$8.4M | -33,664−5.6% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 559,846$8.2M | +287,577+105.6% |
| BOOTHBAY FUND MANAGEMENT, LLCadded · filed 14 Aug 2026 | 529,640$7.7M | +1370.0% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 481,417$7.0M | -20,800−4.1% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 451,095$6.6M | -7,752−1.7% |
| CAPITAL MANAGEMENT CORPadded · filed 29 Jul 2026 | 448,474$6.6M | +753+0.2% |
| DEUTSCHE BANK AG\added · filed 7 Aug 2026 | 353,552$5.2M | +378+0.1% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.